Studies have demonstrated differential associations between the risk factors of ovarian cancer and α-ER and progesterone receptor (PR) status, while no previous research has observed associations of ovarian cancer risk factors with β-ER expression [60,61]. This evidence concerns the gene ESR1 and ovarian cancer.